Ulrik B. Keiding

Ulrik B. Keiding

Auto-generated profile, based on publicly available information

Ulrik B. Keiding

Department of Chemistry, Aarhus University, 8000 Aarhus C, Denmark

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2016 in Nature Chemistry
Verified
Journal Article
Closed access
NVNikolaj L. Villadsen
Nikolaj L. Villadsen
KJKristian M. Jacobsen
Kristian M. Jacobsen
UKUlrik B. Keiding
Ulrik B. Keiding
EWEsben T. Weibel
Esben T. Weibel
BCBjørn Christiansen
Bjørn Christiansen
TPThomas Poulsen
Thomas Poulsen

23 December 2014 in MedChemComm
Verified
Journal Article
Open access
PDF file
KJKristian M. Jacobsen
Kristian M. Jacobsen
UKUlrik B. Keiding
Ulrik B. Keiding
LCLise L. Clement
Lise L. Clement
ESEva S. Schaffert
Eva S. Schaffert
NRNeela D. S. Rambaruth
Neela D. S. Rambaruth
TPThomas Poulsen
Thomas Poulsen
We demonstrate that the natural product brartemicin, a newly discovered inhibitor of cancer cell invasion, is a high-affinity ligand of the carbohydrate-recognition domain (CRD) of the C-type lectin mincle. Recent studies have revealed that mincle is a key macrophage receptor for the mycobacterial virulence factor trehalose dimycolate (TDM), which is a glycolipid component of the mycobacterial cell wall. Major uncertainties, however, remain concerning the mechanism of TDM-binding and subsequent signal transduction as well as interplay of potential co-receptors. Due to the lipid nature of TDM, functional studies are difficult and soluble mincle-ligands are therefore of significant interest. Brartemicin, together with designed analogs also presented in this paper, may thus serve as useful molecular probes for future studies of mincle. Through computational studies, we further provide an insight into the probable mode of binding of brartemicin.